Real world data
Real world data (RWD) in medicine is data derived from a number of sources that are associated with outcomes in a heterogeneous patient population in real-world settings, including but not limited to electronic health records, health insurance claims and patient surveys. While no universal definition of real world data exists, researchers typically understand RWD as distinct from data sourced from randomized clinical trials.[1]
Real world data (RWD) in healthcare
Real-world data refer to
The sources of RWD are only rarely
Real world evidence (RWE)
When working with RWD, the goal is often to generate evidence. The term real world evidence (RWE) is highly related to RWD. RWE is defined by FDA as "clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis of RWD".[4] An example of a study utilizing RWE is "Clinical Features and Outcomes of Coronavirus Disease 2019 Among People Who Have HIV in the United States: A Multi-center Study From a Large Global Health Research Network (TriNetX)" In this study, Covid-19 outcomes were compared between people with HIV and HIV-negative controls from a database of de-identified health records. The TriNetX platform allowed the researchers to consider the HIV and HIV-negative subjects in incidence of hospitalizations, ICU admissions, ventilation and severe disease, to understand the impact Covid-19 infection has on those with HIV.[5]
Regional context
US context
In December 2018, the
EU context
In 2018, the EMA published a discussion paper on the use of patient disease registries for regulatory purposes (methodological and operational considerations).[6] In 2022, UK's National Institute for Health and Care Excellence published its RWE Framework[7] that sets out how RWE could inform health technology assessment.
See also
- 21st Century Cures Act (US)
- Correlation does not imply causation
- Qualitative research
- Quantitative research
- Sentinel Initiative
References
- ^ Cowley, Andrea. "What is real world data?". CRC Australia. Clinical Research Corporation. Retrieved 8 May 2018.
- PMID 33166397.
- ^ "TriNetX and Takeda Enter Into Agreement to Drive Access to Real-World Data and Analytics". TriNetX. 2021-04-26. Retrieved 2022-02-04.
- ^ a b "Framework for FDA's Real-World Evidence Program". FDA.
- PMID 34435074– via Oxford Academic.
- ^ "Use of patient disease registries for regulatory purposes – methodological and operational considerations".
- ^ "Overview | NICE real-world evidence framework | Guidance | NICE". www.nice.org.uk. 23 June 2022. Retrieved 2022-09-06.
Sources
- Real-World Evidence—What Is It and What Can It Tell Us? The New England Journal of Medicine, Dec. 6, 2016
- Mahajan, Rajiv. “Real World Data: Additional Source for Making Clinical Decisions.” International Journal of Applied and Basic Medical Research 5.2 (2015): 82. PMC. Web. 5 May 2018.